Logo image of PNT

POINT BIOPHARMA GLOBAL INC (PNT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PNT - US7305411099 - Common Stock

12.5 USD
+0.02 (+0.16%)
Last: 12/26/2023, 8:10:43 PM
12.51 USD
+0.01 (+0.08%)
After Hours: 12/26/2023, 8:10:43 PM
Fundamental Rating

5

Overall PNT gets a fundamental rating of 5 out of 10. We evaluated PNT against 525 industry peers in the Biotechnology industry. PNT has an excellent financial health rating, but there are some minor concerns on its profitability. PNT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • PNT had positive earnings in the past year.
  • PNT had a positive operating cash flow in the past year.
PNT Yearly Net Income VS EBIT VS OCF VS FCFPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 0 50M -50M 100M 150M

1.2 Ratios

  • PNT has a better Return On Assets (20.22%) than 99.49% of its industry peers.
  • PNT has a Return On Equity of 22.77%. This is amongst the best in the industry. PNT outperforms 97.81% of its industry peers.
  • PNT's Return On Invested Capital of 18.63% is amongst the best of the industry. PNT outperforms 99.33% of its industry peers.
Industry RankSector Rank
ROA 20.22%
ROE 22.77%
ROIC 18.63%
ROA(3y)-20.26%
ROA(5y)N/A
ROE(3y)-32.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PNT Yearly ROA, ROE, ROICPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 20 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of PNT (39.62%) is better than 99.33% of its industry peers.
  • PNT's Operating Margin of 44.22% is amongst the best of the industry. PNT outperforms 98.99% of its industry peers.
Industry RankSector Rank
OM 44.22%
PM (TTM) 39.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PNT Yearly Profit, Operating, Gross MarginsPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PNT is still creating some value.
  • PNT has more shares outstanding than it did 1 year ago.
  • PNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PNT Yearly Shares OutstandingPNT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
PNT Yearly Total Debt VS Total AssetsPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 16.90 indicates that PNT is not in any danger for bankruptcy at the moment.
  • PNT's Altman-Z score of 16.90 is amongst the best of the industry. PNT outperforms 91.23% of its industry peers.
  • The Debt to FCF ratio of PNT is 0.06, which is an excellent value as it means it would take PNT, only 0.06 years of fcf income to pay off all of its debts.
  • PNT's Debt to FCF ratio of 0.06 is amongst the best of the industry. PNT outperforms 97.30% of its industry peers.
  • PNT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • PNT's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. PNT outperforms 43.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.06
Altman-Z 16.9
ROIC/WACC1.67
WACC11.15%
PNT Yearly LT Debt VS Equity VS FCFPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

  • PNT has a Current Ratio of 9.13. This indicates that PNT is financially healthy and has no problem in meeting its short term obligations.
  • PNT has a Current ratio of 9.13. This is in the better half of the industry: PNT outperforms 73.52% of its industry peers.
  • PNT has a Quick Ratio of 9.13. This indicates that PNT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PNT (9.13) is better than 73.69% of its industry peers.
Industry RankSector Rank
Current Ratio 9.13
Quick Ratio 9.13
PNT Yearly Current Assets VS Current LiabilitesPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 195.40% over the past year.
EPS 1Y (TTM)195.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, PNT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.94% on average per year.
  • PNT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.58% yearly.
EPS Next Y9.21%
EPS Next 2Y-2.62%
EPS Next 3Y36.93%
EPS Next 5Y22.94%
Revenue Next Year-14.35%
Revenue Next 2Y21.4%
Revenue Next 3Y112.36%
Revenue Next 5Y72.58%

3.3 Evolution

PNT Yearly Revenue VS EstimatesPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
PNT Yearly EPS VS EstimatesPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.06 indicates a correct valuation of PNT.
  • Based on the Price/Earnings ratio, PNT is valued cheaply inside the industry as 97.47% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 28.60. PNT is valued slightly cheaper when compared to this.
  • PNT is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 15.06
Fwd PE N/A
PNT Price Earnings VS Forward Price EarningsPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PNT is valued cheaply inside the industry as 97.98% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PNT indicates a rather cheap valuation: PNT is cheaper than 97.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.37
EV/EBITDA 6.16
PNT Per share dataPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • PNT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PNT's earnings are expected to grow with 36.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.64
PEG (5Y)N/A
EPS Next 2Y-2.62%
EPS Next 3Y36.93%

0

5. Dividend

5.1 Amount

  • PNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POINT BIOPHARMA GLOBAL INC / PNT FAQ

What is the ChartMill fundamental rating of POINT BIOPHARMA GLOBAL INC (PNT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to PNT.


Can you provide the valuation status for POINT BIOPHARMA GLOBAL INC?

ChartMill assigns a valuation rating of 5 / 10 to POINT BIOPHARMA GLOBAL INC (PNT). This can be considered as Fairly Valued.


What is the profitability of PNT stock?

POINT BIOPHARMA GLOBAL INC (PNT) has a profitability rating of 4 / 10.


What is the financial health of POINT BIOPHARMA GLOBAL INC (PNT) stock?

The financial health rating of POINT BIOPHARMA GLOBAL INC (PNT) is 8 / 10.